Purchase Order 75N91021P00100

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on December 9, 2020, for radioactive standing order supplies with a ceiling value of $11,504.80. Work is performed in Shelton, Connecticut. The order, firm fixed price with no small business set-aside, is scheduled for completion by December 24, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) valued at $178,361.58 on August 23, 2015, for maintenance service of high-throughput microscopy, automated image plate loading/unloading, and liquid handling equipment. The order carries a firm fixed-price structure with no small business set-aside. Work is performed in Bethesda, Maryland, with an ultimate completion date of August 22, 2016.</p>

<p>The National Cancer Institute issued a delivery order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on August 15, 2018, with a ceiling value of $49,760.30 under the Scientific Equipment and Services GSA Schedule (FSS-66).</p> <p>Place of performance is Bethesda, MD. The order was firm fixed price with an ultimate completion date of September 15, 2018. No set-aside was used.</p>

<p>The National Cancer Institute issued a purchase order to Revvity Health Sciences, Inc. for $18,108.48 on December 31, 2019, to provide service coverage for the Genetics Branch PerkinElmer Ensight system during the period January 1, 2020 through December 31, 2020. No set-aside was used. Work is performed at Bethesda, Maryland. The order is firm fixed-price with no further period of performance extensions noted.</p>

Revvity Health Sciences, Inc., doing business as PerkinElmer Inc., received a $4,539.60 firm fixed-price Blanket Purchase Agreement (BPA) call from the National Cancer Institute (NCI) on January 29, 2016, with a completion date of March 31, 2016. The work is to be performed in Bethesda, Maryland. This award represents a task order issued under an existing BPA vehicle and was not designated as a small business set-aside. Revvity Health Sciences, a large business contractor and subsidiary of...

Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a Blanket Purchase Agreement (BPA) call valued at $3,656.64 by the National Cancer Institute on March 3, 2016, with an ultimate completion date of March 31, 2017. This firm fixed-price contract, issued without a small business set-aside, was performed in Bethesda, Maryland and represents a task order against a larger BPA vehicle. As a large business contractor, Revvity Health Sciences specializes in medical imaging...

This is a $18,290 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The service agreement has an ultimate completion date of January 11, 2026. Revvity Health Sciences is a for-profit organization that manufactures medical imaging products and equipment. The company has previously received prime contracts, subcontracts, and indefinite delivery vehicle awards from federal agencies like the NIH, CDC,...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $18,406.00 on December 17, 2020, for maintenance renewal services. Work is performed in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion is December 17, 2020.</p>

PerkinElmer Inc., operating as Revvity Health Sciences, Inc., received a $10,108 firm fixed-price Blanket Purchase Agreement (BPA) call award from the National Cancer Institute (NCI) on May 19, 2015, with an ultimate completion date of June 19, 2015. The contract was performed in Shelton, Connecticut, and did not utilize a set-aside designation, reflecting the contractor's status as a large business. As a child entity of Revvity Inc., PerkinElmer Health Sciences specializes in medical imaging...

This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, part of the National Institutes of Health, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract, valued at $365,598.51, is to provide a service protection plan to ensure that critical research instruments are always available and in good working condition for the agency's research staff. The contract has a completion date of November 29, 2024, and does not include any...